An Eli Lilly and Company pharmaceutical manufacturing facility is pictured at 50 ImClone Drive on March 50, 2021 in Branchburg, New Jersey. Fresh Mike | Reuters The Alzheimer’s treatment Donanemab, which is manufactured by Eli Lillisignificantly slowed the progression of the mind-numbing disease, according to clinical trial data released by the company on Wednesday. Patients…

Pfizer on Tuesday reported first-quarter sales and adjusted earnings that beat Wall Street expectations, despite a decline in sales attributed to lower demand for the company’s Covid vaccine. Shares of the pharmaceutical giant were largely unchanged on Tuesday. Shares are down more than 23% for the year through Monday’s close, putting the company’s market value…

Alex Huth (left), Shailee Jain (center) and Jerry Tang (right) prepare to collect brain activity data at the University of Texas Biomedical Imaging Center at Austin. The researchers trained their semantic decoder using dozens of hours of participants’ brain activity data collected in an fMRI scanner. Photo: Nolan Zuk/University of Texas at Austin. Scientists have…

Juanmonino | E+ | Getty Images Seniors with early Alzheimer’s disease will face major hurdles to get treated even if promising new drugs roll out more broadly in the coming years, putting them at risk of developing more severe disease as they wait months or perhaps years for a diagnosis. The U.S. health-care system is…

patients who have taken Eli Lilli‘s weight-loss drug, Tirzepatide, lost an average of up to 34 pounds, or 16% of her body weight, the company said in clinical trial results released Thursday. Eli Lilly plans to complete its application for approval of the drug by the Food and Drug Administration in the coming weeks, and…

Carl Icahn speaks at Delivering Alpha in New York on September 13, 2016. David A Grogan | CNBC Carl Icahn called on Friday illuminas first-quarter results were “very disappointing” and slammed the DNA sequencing company’s new cost-cutting plans. The activist investor, which owns a 1.4% stake in Illumina, is in a heated proxy battle with…

note on Thursday reported first-quarter sales and adjusted earnings that beat Wall Street expectations, despite a sharp drop in sales of its Covid antiviral treatment molnupiravir. Sales of molnupiravir collapsed to $392 million during the period, down 88% from the $3.2 billion reported for the first quarter of 2022. Merck said the decline was primarily…

Medical bottles and syringes with the logo of Eli Lilly and Company are seen on a screen in the background in this illustrative photo taken in Krakow, Poland, on November 10, 2022. Jakub Porzycki | Nurphoto | Getty Images Eli LilliFirst-quarter results missed expectations on Thursday, but the drug company raised its full-year guidance. Before…

Chiquita Brooks-LaSure testifies before the Senate Finance Committee during her nomination hearing for Administrator of the Centers for Medicare & Medicaid Services in Washington on Thursday, April 15, 2021. Caroline Brehmann | CQ Roll Call, Inc. | Getty Images Medicare will cover new Alzheimer’s treatment Leqembi for all patients eligible under the drug’s label when…

A building on the Illumina World Headquarters campus is shown on September 1, 2021 in San Diego, California. Mike Blake | Reuters Enlightenment on Tuesday unveiled cost-cutting plans to improve the DNA sequencing company’s shrinking margins. The plans aim to cut Illumina’s annualized spend by more than $100 million starting later this year, according to…